Skip to content

Treatment for male Impotency

Evaluation of efficacy of vatsyayan plus (capsule)in the management of male impotency -Double blind placebo control clinical study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/10/009962
Enrollment
104
Registered
2017-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- 104 patients with Male Impotency, meeting all inclusion/exclusion criteria will be included for the study

Interventions

Intervention1: Vatsyayan Plus: It contains Ayurvedic drugs like Atmagupta, Gokshura, Vidarikanda, Safed musali,Shalmali, Sh.Shilajatu, Ashwagandha, Jasada bhasma, Swarna bhasma, SIddhamakardwaja, Muk

Sponsors

MB Life Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects with Male Impotency fulfilling the diagnostic criteria of IIEF-15 2.Subjects with signs & symptoms of Klaibya 3.Male subjects with age between 21-45 years 4.Willing to give consent for participating in the study

Exclusion criteria

Exclusion criteria: 1.Subjects with H/o BPH, Severe HTN & cardiac disease 2.Sexually transmitted diseases. 3.Patients with other major systemic disorders which interfere with the treatment will be excluded 4.Known case of genetic abnormalities. 5.Patients with known major psychological disorders. 6.Spinal injury and major pelvic surgery. 7.Pyeronieâ??s disease. 8.Priapism. 9.Any other conditions which in the opinion of investigator will place the subject at risk or will influence the conduct of study or interpretation of results

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of capsule Vatsyayan plus in the management of male impotencyTimepoint: Day -1,0,1-30,30,60

Secondary

MeasureTime frame
To evaluate the efficacy of capsule Vatsyayana plusTimepoint: Safety Parameters such as CBC, LFT, and RFT will be done on 0th and 30th day in 50% of subjects. Efficacy (Primary): (Before and after the treatment period of 30 days) Changes in following parameters between day 1 and day 30: Subjective parameters: IIEF -15 Questionnaire Objective parameters: Testosterone, FSH, LH, semen analysis

Countries

India

Contacts

Public ContactDrSukumar Nandigoudar

KLEUs Shri BMK Ayurveda Mahavidyalaya, Belagavi

vaidyasukumar@gmail.com9986125625

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026